Key Statistics
About Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Analyst Ratings
View All →| Date | Firm | Rating |
|---|---|---|
| Jan 20, 2026 | Guggenheim | |
| Dec 15, 2025 | B of A Securities | |
| Dec 10, 2025 | Wells Fargo | |
| Dec 4, 2025 | BMO Capital | |
| Nov 24, 2025 | Bernstein |